1. Founding of Helix Biogen Consult (Late 2019)

Helix Biogen Consult was established as a consultancy firm to provide expert services in biomedical research, diagnostics, and biotechnology solutions.

• Hands-on training in molecular biology techniques.
• Collaborations with academic institutions on lab capacity-building.
• Preliminary research on diagnostics and vaccine approaches.

2. Expansion to Research-Based Projects (2020)

During COVID-19, the organization pivoted to applied biomedical research including vaccine development.

• Initiated COVID-19 vaccine research for African populations.
• Vaccine candidate recognized by WHO in the global landscape.

3. Transition to a Biomedical Research Institute (Mid-2021)

To reflect its expanded mission, Helix Biogen transitioned into a biomedical institute.

• Founded a research hub in Ogbomoso, Nigeria.
• Secured local and international academic and industry partnerships.
• Expanded into translational genomics and diagnostic kit development.

4. Key Achievements as Helix Biogen Institute (2022 – Present)

• Advanced preclinical work on COVID-19 vaccine candidate.
• Developed point-of-care diagnostic kits for Africa CDC-prioritized pathogens.
• Published mRNA vaccine studies for vaccinia and Mpox viruses.
• Hosted biotech entrepreneurship and lab training programs.
• Collaborated with Africa CDC and public health agencies.